{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:18:10Z","timestamp":1792153090103,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.exger.2024.112431","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T15:59:37Z","timestamp":1713542377000},"page":"112431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The effect of tamoxifen on estradiol, SHBG, IGF-1, and CRP in women with breast cancer or at risk of developing breast cancer: a meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"191","author":[{"given":"XingDa","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XueJiao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hern\u00e1ndez-Wolters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousalya","family":"Prabahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Kord-Varkaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exger.2024.112431_bb0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.exger.2024.112431_bb0010","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/annonc\/mdi322","article-title":"Comparative effects of anastrozole, tamoxifen alone and in combination on plasma lipids and bone-derived resorption during neoadjuvant therapy in the impact trial","volume":"16","author":"Banerjee","year":"2005","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.exger.2024.112431_bb0015","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1158\/1078-0432.CCR-0433-03","article-title":"Long-term exposure to tamoxifen induces hypersensitivity to estradiol","volume":"10","author":"Berstein","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.exger.2024.112431_bb0020","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1078-0432.CCR-20-3609","article-title":"A randomized phase IIb study of low-dose tamoxifen in chest-irradiated cancer survivors at risk for breast cancer","volume":"27","author":"Bhatia","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.exger.2024.112431_bb0025","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1046\/j.1538-7836.2003.00392.x","article-title":"Effect of tamoxifen at low doses on ultrasensitive C-reactive protein in healthy women","volume":"1","author":"Bonanni","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.exger.2024.112431_bb0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1677\/joe.0.1190335","article-title":"Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain","volume":"119","author":"Caleffi","year":"1988","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.exger.2024.112431_bb0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/mp.54.5.307","article-title":"IGF status is altered by tamoxifen in patients with breast cancer","volume":"54","author":"Campbell","year":"2001","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.exger.2024.112431_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-015-0291-7","article-title":"The role of the insulin-like growth factor-1 system in breast cancer","volume":"14","author":"Christopoulos","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.exger.2024.112431_bb0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/gyno.1998.5201","article-title":"Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients","volume":"72","author":"Cohen","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.exger.2024.112431_bb0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/01.ATV.21.2.255","article-title":"Tamoxifen and cardiac risk factors in healthy women - suggestion of an anti-inflammatory effect","volume":"21","author":"Cushman","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.exger.2024.112431_bb0055","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jnci\/95.11.779","article-title":"A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers","volume":"95","author":"Decensi","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.exger.2024.112431_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41523-021-00236-6","article-title":"Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial","volume":"7","author":"Decensi","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.exger.2024.112431_bb0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/1097-0142(19850701)56:1<63::AID-CNCR2820560111>3.0.CO;2-7","article-title":"Chemohormonal therapy and endocrine function in breast cancer patients","volume":"56","author":"Dnistrian","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.exger.2024.112431_bb0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0960-0760(03)00365-0","article-title":"Hormonal effects of aromatase inhibitors: focus on premenopausal effects and interaction with tamoxifen","volume":"86","author":"Dowsett","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.exger.2024.112431_bb0075","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Bmj"},{"key":"10.1016\/j.exger.2024.112431_bb0080","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/0959-8049(93)90003-X","article-title":"Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy","volume":"29","author":"Friedl","year":"1993","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.exger.2024.112431_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-10-313","article-title":"Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer","volume":"10","author":"Gjerde","year":"2010","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.exger.2024.112431_bb0090","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0014-2964(76)90022-0","article-title":"Plasma hormones in patients with advanced breast cancer treated with tamoxifen","volume":"1965","author":"Golder","year":"1976","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.exger.2024.112431_bb0095","series-title":"GSe. Cochrane Handbook for Systematic Reviews of Interventions Version, 5","author":"Higgins","year":"2011"},{"key":"10.1016\/j.exger.2024.112431_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.exger.2024.112431_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.641449","article-title":"Role of the IGF-1 axis in overcoming resistance in breast cancer","volume":"9","author":"Ianza","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.exger.2024.112431_bb0110","unstructured":"Iyengar, N. M., Arthur, R., Manson, J. E., Chlebowski, R. T., Kroenke, C. H., Peterson, L., Cheng, T.-Y. D., Feliciano, E. C., Lane, D. & Luo, J. Body fat and risk of breast cancer in postmenopausal women with normal body mass index: a secondary analysis of the women's health initiative randomized clinical trials and observational study. JAMA Oncol."},{"key":"10.1016\/j.exger.2024.112431_bb0115","doi-asserted-by":"crossref","first-page":"9512","DOI":"10.1158\/0008-5472.CAN-08-0553","article-title":"Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer","volume":"68","author":"Johansson","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.exger.2024.112431_bb0120","first-page":"1323","article-title":"Early effects of adjuvant tamoxifen therapy on serum hormones, proteins and lipids","volume":"20","author":"Kailaj\u00e4rvi","year":"2000","journal-title":"Anticancer Res."},{"key":"10.1016\/j.exger.2024.112431_bb0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.mrfmmm.2005.02.028","article-title":"Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance","volume":"591","author":"Lewis","year":"2005","journal-title":"Mutat. Res. Fundam. Mol. Mech. Mutagen."},{"key":"10.1016\/j.exger.2024.112431_bb0130","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/jnci\/82.16.1327","article-title":"Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer","volume":"82","author":"Love","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.exger.2024.112431_bb0135","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ptj\/89.9.873","article-title":"Reprint\u2014preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"89","author":"Moher","year":"2009","journal-title":"Phys. Ther."},{"key":"10.1016\/j.exger.2024.112431_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10549-008-9985-5","article-title":"Correlates of circulating C-reactive protein and serum amyloid a concentrations in breast cancer survivors","volume":"114","author":"Pierce","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.exger.2024.112431_bb0145","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/jnci\/82.21.1693","article-title":"Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients","volume":"82","author":"Pollak","year":"1990","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.exger.2024.112431_bb0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-5122(01)00230-4","article-title":"Effects of HRT on serum levels of IGF-I in postmenopausal women","volume":"40","author":"Posaci","year":"2001","journal-title":"Maturitas"},{"key":"10.1016\/j.exger.2024.112431_bb0155","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/0277-5379(90)90116-B","article-title":"Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme","volume":"26","author":"Powles","year":"1990","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.exger.2024.112431_bb0160","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.exger.2024.112431_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01352006","article-title":"Effect of estrogen deficiency on IGF-I plasma levels: relationship with bone mineral density in perimenopausal women","volume":"53","author":"Romagnoli","year":"1993","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.exger.2024.112431_bb0170","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1634\/theoncologist.2011-0369","article-title":"Tamoxifen alters the plasma concentration of molecules associated with cardiovascular risk in women with breast cancer undergoing chemotherapy","volume":"17","author":"Romero","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.exger.2024.112431_bb0175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1677\/joe.0.0760219","article-title":"Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast","volume":"76","author":"Sakai","year":"1978","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.exger.2024.112431_bb0180","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/bcr3439","article-title":"A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer","volume":"15","author":"Serrano","year":"2013","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.exger.2024.112431_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-018-0472-8","article-title":"Estrogen alpha receptor antagonists for the treatment of breast cancer: a review","volume":"12","author":"Sharma","year":"2018","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.exger.2024.112431_bb0190","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-reactive protein at sites of inflammation and infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exger.2024.112431_bb0195","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.2147\/OTT.S172149","article-title":"Estrogen affects cell growth and IGF-1 receptor expression in renal cell carcinoma","author":"Sun","year":"2018","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.exger.2024.112431_bb0200","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000226095","article-title":"Hormonal changes during a prolonged tamoxifen treatment in patients with advanced breast cancer","volume":"43","author":"Sz\u00e1mel","year":"1986","journal-title":"Oncology"},{"key":"10.1016\/j.exger.2024.112431_bb0205","first-page":"4384","article-title":"Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors","volume":"63","author":"Wu","year":"2003","journal-title":"Cancer Res."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556524000731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556524000731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T13:48:51Z","timestamp":1745416131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556524000731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":41,"alternative-id":["S0531556524000731"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2024.112431","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of tamoxifen on estradiol, SHBG, IGF-1, and CRP in women with breast cancer or at risk of developing breast cancer: a meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2024.112431","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112431"}}